Drug Manufacturers
- 754.637
- +5.346+0.71%
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
AU Evening Wrap | ASX 200 Slips to a 5-Week Low on Bank Stocks Sell-Off; QBE Bucks the Trend with Strong Earnings
AU Morning Wrap: ASX Flat; Life360 Climbs Over 3%
AU Morning Wrap: ASX Slides; Gold and Oil Slip
AU Morning Wrap: ASX Shares Drop; Energy Producers Rise
AU Morning Wrap: ASX Slumps 1.5% in Broad Losses, Costa Group, News Corp Rally
AU Morning Wrap: ASX Flat; AMA Group Plunges 45% After $55m Raise
AU Morning Wrap: ASX Rallies, Liontown Soars 10%